Osmosis Investment Management UK Ltd bought a new stake in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 10,576 shares of the technology company's stock, valued at approximately $3,856,000.
Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Celestica by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 4,811,695 shares of the technology company's stock worth $1,423,333,000 after acquiring an additional 73,022 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Celestica by 24.8% during the fourth quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company's stock worth $1,187,650,000 after purchasing an additional 798,782 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Celestica by 5,806,149.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,657,937 shares of the technology company's stock valued at $1,081,323,000 after purchasing an additional 3,657,874 shares during the period. Franklin Resources Inc. grew its holdings in Celestica by 18.6% during the 4th quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company's stock valued at $673,471,000 after purchasing an additional 356,797 shares in the last quarter. Finally, Cibc World Market Inc. increased its stake in Celestica by 30.6% during the 4th quarter. Cibc World Market Inc. now owns 2,265,680 shares of the technology company's stock worth $670,279,000 after buying an additional 530,535 shares during the period. 67.38% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
CLS has been the topic of a number of recent analyst reports. Rothschild & Co Redburn assumed coverage on shares of Celestica in a report on Friday, May 1st. They issued a "buy" rating and a $460.00 price objective on the stock. The Goldman Sachs Group reaffirmed a "buy" rating and set a $475.00 target price on shares of Celestica in a research report on Tuesday, April 28th. Citigroup boosted their price target on Celestica from $338.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, April 29th. TD Securities raised Celestica from a "hold" rating to a "buy" rating and set a $430.00 price target for the company in a report on Wednesday, April 29th. Finally, JPMorgan Chase & Co. raised their price objective on Celestica from $445.00 to $485.00 and gave the company an "overweight" rating in a research note on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Celestica currently has a consensus rating of "Buy" and an average target price of $439.81.
Check Out Our Latest Analysis on CLS
Insiders Place Their Bets
In other Celestica news, CEO Robert Mionis sold 98,453 shares of the stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $368.99, for a total transaction of $36,328,172.47. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Mandeep Chawla sold 17,000 shares of the firm's stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the completion of the transaction, the chief financial officer owned 82,444 shares in the company, valued at approximately $32,948,744.60. The trade was a 17.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 356,553 shares of company stock valued at $135,238,444. 1.10% of the stock is currently owned by corporate insiders.
Celestica Stock Performance
Shares of CLS stock opened at $296.03 on Monday. The stock has a market capitalization of $34.04 billion, a price-to-earnings ratio of 30.77 and a beta of 2.06. Celestica, Inc. has a one year low of $179.01 and a one year high of $474.02. The company's 50-day simple moving average is $341.15 and its 200-day simple moving average is $335.51. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23.
Celestica (NYSE:CLS - Get Free Report) TSE: CLS last issued its earnings results on Monday, July 27th. The technology company reported $2.54 EPS for the quarter, topping the consensus estimate of $2.29 by $0.25. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The company had revenue of $4.68 billion during the quarter, compared to analyst estimates of $4.30 billion. During the same quarter last year, the firm earned $1.39 EPS. The business's revenue was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Equities analysts anticipate that Celestica, Inc. will post 10.15 earnings per share for the current fiscal year.
Celestica Company Profile
(
Free Report)
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
